Please use this identifier to cite or link to this item:
Title: Prevention and management of TURP-related hemorrhage.
Austin Authors: Kavanagh, Liam E;Jack, Gregory S ;Lawrentschuk, Nathan
Institutional Author: Medscape
Affiliation: University of Melbourne, Department of Surgery, Ludwig Institute for Cancer Research, Austin Hospital, Studley Road, Heidelberg, Melbourne, Vic 3084, Australia
Issue Date: 16-Aug-2011
Publication information: Nature Reviews. Urology 2011; 8(9): 504-14
Abstract: Transurethral resection of the prostate (TURP) is the most common surgical treatment for benign prostatic hyperplasia (BPH) worldwide, but despite its minimally invasive nature, perioperative bleeding remains a common morbidity. Anticoagulant and antiplatelet medications are increasingly common in this patient population and further contribute to the risk of bleeding and extended hospital stay. Preoperative cessation of anticoagulant and antiplatelet drugs is recommended but requires risk assessment of thrombotic complications. Pharmacologic maneuvers to reduce hemorrhage include perioperative administration of 5α-reductase inhibitors. Technical considerations include the use of hemostatic energy sources such as laser and bipolar technologies. Ultimately, no surgical technique is devoid of bleeding risks, and urologists should be aware of how best to prevent and treat TURP-related hemorrhage.
Gov't Doc #: 21844906
DOI: 10.1038/nrurol.2011.106
Journal: Nature reviews. Urology
Type: Journal Article
Subjects: Animals
Disease Management
Laser Therapy.methods
Platelet Aggregation Inhibitors.therapeutic use
Postoperative Hemorrhage.etiology.prevention & control.therapy
Transurethral Resection of Prostate.adverse effects
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Jan 27, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.